Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Change in Receivables (2016 - 2025)

INVO Fertility (IVF) has disclosed Change in Receivables for 15 consecutive years, with $31945.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Receivables rose 20191.19% to $31945.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $17149.0, a 87.77% decrease, with the full-year FY2024 number at $34331.0, down 45.85% from a year prior.
  • Change in Receivables was $31945.0 for Q3 2025 at INVO Fertility, down from $68641.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $505952.0 in Q1 2021 to a low of -$479782.0 in Q2 2021.
  • A 5-year average of $13289.5 and a median of $8250.0 in 2022 define the central range for Change in Receivables.
  • Peak YoY movement for Change in Receivables: crashed 1010.16% in 2023, then surged 20191.19% in 2025.
  • INVO Fertility's Change in Receivables stood at -$189.0 in 2021, then surged by 3188.89% to $5838.0 in 2022, then skyrocketed by 307.14% to $23769.0 in 2023, then crashed by 445.7% to -$82170.0 in 2024, then soared by 138.88% to $31945.0 in 2025.
  • Per Business Quant, the three most recent readings for IVF's Change in Receivables are $31945.0 (Q3 2025), $68641.0 (Q2 2025), and -$1267.0 (Q1 2025).